| MSI |
Report |
Q2 2026 revenue |
BEAT |
pred ~$3.04B vs. cons $3.00B |
MEDIUM |
| MSI |
Report |
Q2 2026 adjusted EPS |
BEAT |
pred ~$3.96 vs. cons $3.85 |
MEDIUM |
| MSI |
Report |
Q2 2026 organic revenue growth |
BEAT |
pred ~1.5% vs. cons 1.0% |
LOW |
| MSI |
Guide |
Q3 2026 revenue growth |
BETTER |
guide ~10.5% vs. cons 10.2% (Q3 2026) |
MEDIUM |
| MSI |
Guide |
Q3 2026 adjusted EPS |
BETTER |
guide ~$4.55 vs. cons $4.49 (Q3 2026) |
MEDIUM |
| MSI |
Guide |
FY2026 revenue |
BETTER |
guide ~$12.90B vs. cons $12.84B (FY2026) |
MEDIUM |
| MSI |
Guide |
FY2026 adjusted EPS |
BETTER |
guide ~$17.14 vs. cons $17.02 (FY2026) |
MEDIUM |
| MSI |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.1% |
— |
LOW |
| MSI |
Return |
5-day cumulative residual |
+1.8% (FADE) |
The projected FY2026 EPS guide rises ~$0.12 versus consensus while the Q2 beat is ~$0.11, leaving only ~$0.01 of implied second-half upside; similarly, the ~$60M FY revenue uplift versus consensus exceeds the ~$40M Q2 beat by only ~$20M, so limited out-period revisions should partially fade the initial reaction. |
LOW |